A recent study indicates that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who stop conventional diet and exercise regimens.
Published data in a major medical journal demonstrates that while obese people frequently drop about a fifth of their total mass while on the medication, the weight returns at an average rate of nearly a kilo each month after stopping.
"People purchasing these drugs should be aware of the danger of rapid weight regain when the therapy concludes," stated expert Dr. Susan Jebb.
This pace of recovery means a return to original mass within about 18 months.
Weighing Approaches
The analysis, which examined dozens of studies involving thousands of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers point out that people who lose weight through dieting generally experience a more gradual creep back—perhaps 0.1 kg a month—once they finish.
Explaining the Quick Rebound
Nutrition scientists believe the mode of action of the injections is key to understanding the heightened regain.
GLP-1 drugs copy a natural hormone called GLP-1, which moderates appetite.
"Long-term administration of GLP-1 levels far above than the body's typical production could lead to the body to produce less of its own natural GLP-1, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication results in hunger is uncontrolled, making overeating far more likely."
An Ongoing Disease?
Medical guidelines suggest the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, considering the significant potential of relapse, the treatment should be considered ongoing.
This opinion is supported by drug manufacturers, who say that the results "highlight the chronic nature of excess weight," comparing it to managing diseases like diabetes.
Patient Testimonies
People who have stopped the jabs report a powerful resurgence of hunger.
"I experienced a switch flipping and I was suddenly ravenous," described an individual.
The struggle is compounded if individuals have not established sustainable dietary or behavioural changes during treatment.
Growing Interest
Survey data suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is more common among females compared to men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while GLP-1 drugs are potent tools for shedding pounds, they are not a standalone fix and long-term success hinges on combined lifestyle changes.
